Reported Q: Q1 2024 Rev YoY: -34.7% EPS YoY: -177.6% Move: -5.39%
Centrus Energy Corp
LEU
$182.90 -5.39%
Exchange NYSE Sector Energy Industry Uranium
Q1 2024
Published: May 8, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for LEU

Reported

Report Date

May 8, 2024

Quarter Q1 2024

Revenue

43.70M

YoY: -34.7%

EPS

-0.38

YoY: -177.6%

Market Move

-5.39%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $43.70M down 34.7% year-over-year
  • EPS of $-0.38 decreased by 177.6% from previous year
  • Gross margin of 7.3%
  • Net income of -6.10M
  • "Between HALEU and LEU, we see a tremendous opportunity to address a large and critical market as the only publicly traded enrichment company and the only company in the United States to hold necessary licenses to produce both HALEU and LEU." - Amir Vexler
LEU
Company LEU

Swipe to view all report sections

Executive Summary

Centrus Energy Corp reported Q1 2024 total revenue of $43.7 million, gross profit of $3.2 million, and a net loss of $6.1 million. The company reiterates the earnings cadence for this industry: quarterly revenue is heavily lumpy due to multiyear contracts, with deliveries booked when customers take delivery rather than when contracts are signed. Despite a weak quarter on a GAAP basis, management underscored meaningful progress across HALEU and LEU initiatives and highlighted several catalysts that could drive a multi-year expansion in enrichment capacity and U.S. self-reliance in nuclear fuel. Notably, Centrus announced HALEU milestones (135 kg cumulative production) and detailed a robust funding pipeline, including roughly $900 million in conditional LEU sales commitments and a potential $2.7 billion in federal support for domestic HALEU/LEU production. The company projects that a public-private partnership will be essential to scale operations, aided by recent policy developments (Russia uranium ban effective 90 days after signature with a waiver process through 2028) and a broad government push to triple nuclear energy by 2050. Liquidity remains strong with $209.3 million in cash and $32.6 million in restricted cash, totaling $241.9 million. However, management cautions that Q1 patterns tend to normalize later in the year as deliveries accelerate, and near-term profitability will continue to depend on contract mix, margin resilience, and the pace of policy-driven investments.

Key takeaways for investors include: (1) a tangible pathway to expanded LEU/HALEU production through public-private partnerships and DOE funding; (2) improving profitability signals in Technical Solutions, offsetting LEU softness; (3) notable liquidity that funds ongoing capex and working capital during an investment cycle; and (4) meaningful geopolitical and policy tailwinds that could transform Centrus from a niche US enrichment supplier to a leading domestic producer of HALEU and LEU. Investors should monitor the waiver process timing, cylinder supply stabilization for HALEU production, DOE funding allocations, and the pace at which private sector commitments translate into definitive contracts and capacity expansion.

Key Performance Indicators

Revenue
Decreasing
43.70M
QoQ: -57.82% | YoY: -34.68%
Gross Profit
Decreasing
3.20M
7.32% margin
QoQ: -93.57% | YoY: -86.09%
Operating Income
Decreasing
-10.60M
QoQ: -132.52% | YoY: -227.71%
Net Income
Decreasing
-6.10M
QoQ: -110.83% | YoY: -184.72%
EPS
Decreasing
-0.38
QoQ: -110.44% | YoY: -177.55%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 73.10 1.60 +67.3% View
Q4 2024 151.60 3.20 +46.3% View
Q3 2024 57.70 -0.30 +12.5% View
Q2 2024 189.00 1.89 +92.1% View
Q1 2024 43.70 -0.38 -34.7% View